PDG-PET response to induction chemotherapy could be a useful imaging biomarker to identify patients with esophageal adenocarcinoma who could benefit from subsequent esophagectomy after chemoradiotherapy [24]. This evidence concerns the gene PHGDH and esophageal adenocarcinoma.